相关实验视频

Updated: Jun 3, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

应用人工智能来揭示凝血因子的遗传情景

Giulia Soldà¹, Rosanna Asselta¹

¹Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Medical Genetics and RNA Biology Unit, Rozzano, Milan, Italy.

Journal of thrombosis and haemostasis : JTH

|January 11, 2025

概括

人工智能 (AI) 和机器学习 (ML) 正在加强对凝血因子缺陷中的遗传变异的识别和解释. 这些先进的方法显示出对血友病等出血障碍的个性化治疗有前途.

科学领域:

遗传学是一个遗传学.
生物信息学是一种生物信息学.
计算生物学计算生物学

背景情况:

凝血因子缺陷,如血友病A和B,与特定的遗传变异有关.
传统的变体解释方法可能耗时且复杂.
人工智能 (AI) 的快速发展为遗传分析提供了新的可能性.

研究的目的:

审查AI的应用,特别是机器学习 (ML),在过去十年的凝血遗传学.
突出AI/ML工具用于在凝血障碍中检测和解释遗传变异.
讨论AI在这个领域的优势,局限性和未来方向.

主要方法:

对AI和ML在凝血遗传学中的应用进行系统审查.
对人工智能相关出版物趋势的分析,重点关注血友病.
对预测变异影响和基因型-表型相关性的人工智能工具的评估.

主要成果:

在凝血遗传学方面,人工智能相关的研究显著增加,特别是在A型和B型血友病方面.
ML模型在预测遗传变异的功能影响方面表现出有效性 (例如,因子VIII的Hema-Class).
目前的人工智能方法主要集中在误解突变上,这表明需要更广泛的变异分析.

结论:

人工智能和机器学习是解释凝血障碍中的遗传变异的强大工具.
未来将人工智能整合到变异调用和解释中,将有助于改进大规模基因组数据的处理.
多种AI模型的协同应用和强大的验证对于推进个性化治疗策略至关重要.

关键词:

人工智能 (AI) 是一种人工智能.血液凝固因子是血液凝固因子.遗传学遗传学遗传学遗传学是一个遗传学遗传学遗传学是一个突变是一种突变.多形态主义的多态主义.

更多相关视频

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...